Ebola virus response “inadequate” to match new potential mutations

MSB

In the wake of President Obama’s announced plans to redouble U.S. emergency aid efforts to fight the epidemic, there are fears that the virus could evolve new mutations and could go airborne.

There is increasing concern that the virus could acquire mutations that make it more easily spread or even airborne. A study published in the journal Eurosurveillance found that in Guinea, Liberia, and Sierra Leone – three countries that have been hit the hardest by the epidemic – for each person infected with Ebola between June and August, as many as two other people contracted the virus.

Although such numbers must be interpreted with caution (as they rest on an assumption of continued exponential growth within 2014, which is unlikely), our study supports the notion that the ongoing Ebola virus disease epidemic must be regarded as a Public Health Emergency of International Concern.

Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy, expressed concern in a New York Times op-ed that the rate of new Ebola cases might actually increase if unpredictable mutations make the virus harder to control.

Viruses like Ebola are notoriously sloppy in replicating, meaning the virus entering one person may be genetically different from the virus entering the next. The current Ebola virus’s hyper-evolution is unprecedented; there has been more human-to-human transmission in the past four months than most likely occurred in the last 500 to 1,000 years. Each new infection represents trillions of throws of the genetic dice.

In its current form, Ebola is only capable of being spread from person to person by bodily fluids. Its rapid rate of mutation, Osterholm explains, could lead to the virus being transmissible by air. If this happens, containing Ebola will become an even more daunting task than it already is, and a global pandemic could ensue.

How serious a threat is this scenario? According to William Schaffner, infectious disease expert at Vanderbilt University, it is possible but highly unlikely that Ebola would mutate to become airborne.

Still, conditions are presently bad enough in areas that are already affected to warrant an international response. West Africa’s climate, poverty rates and political climate make infectious disease outreach difficult in the best circumstances: some members of a team of health workers and educators were killed in Guinea in a public riot against Ebola clinics. As Osterholm explains:

We have to remember that Ebola isn’t West Africa’s only problem. Tens of thousands die there each year from diseases like AIDS, malaria and tuberculosis. Liberia, Sierra Leone and Guinea have among the highest maternal mortality rates in the world. Because people are now too afraid of contracting Ebola to go to the hospital, very few are getting basic medical care.

To make matters worse, the already severe shortage of doctors in Liberia – 250 for four million people – is becoming even more serious due to health care workers contracting Ebola.

For humanitarian reasons, world leaders should be pulling out all the stops to properly treat Ebola patients, prevent the virus from spreading to more populations, and develop a vaccine to stop it. Richard E. Besser, former director of the Centers for Disease Control and Prevention, asserts little doubt that current efforts are not sufficient to address the Ebola crisis.

I speak from sad experience: The level of response to the Ebola outbreak is totally inadequate. At the CDC, we learned that a military-style response during a major health crisis saves lives. In a global setting, the CDC usually provides technical support to local ministries of health. This crisis calls for much more.

Additional Resources:

 

 

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
covid-vaccine
Blocked by Kennedy’s CDC, validated by peer-reviewed scientists: Suppressed COVID vaccine study published in JAMA finds 50% risk cut
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
Sampling_a_strawberry_32206461974
Viewpoint: Which is worse: Trace PFAS ‘forever chemicals’ on strawberries or the fear that scares people away from eating them?
NYPICHPDPICT000011561063
Viewpoint: From magnetizing your head to taking useless supplements, the wellness craze has morphed into an obsession of the affluent
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-25-at-4.08.41-PM
Even in blue states, hospitals have continued to drop gender-affirming care for youths
Podolay_1_transplantacia_srdca_1968
From printers to pigs: The precarious future of organ transplants
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.